Journal article

The role of mobile health technologies in allergy care: An EAACI position paper.

  • Matricardi PM Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine, Charité - University Medicine Berlin, Berlin, Germany.
  • Dramburg S Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine, Charité - University Medicine Berlin, Berlin, Germany.
  • Alvarez-Perea A Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Antolín-Amérigo D Department of Allergy, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
  • Apfelbacher C Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Atanaskovic-Markovic M Faculty of Medicine, University Children's Hospital, University of Belgrade, Belgrade, Serbia.
  • Berger U Department of Oto-Rhino-Laryngology, Medical University of Vienna, Vienna, Austria.
  • Blaiss MS Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
  • Blank S Center of Allergy and Environment (ZAUM), School of Medicine and Helmholtz Center Munich, Technical University of Munich, Munich, Germany.
  • Boni E Allergy Unit, Santo Spirito Hospital, Alessandria, Italy.
  • Bonini M National Heart and Lung Institute, Royal Brompton Hospital & Imperial College London, London, UK.
  • Bousquet J University Hospital, Montpellier, France.
  • Brockow K Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
  • Buters J Center of Allergy and Environment (ZAUM), School of Medicine and Helmholtz Center Munich, Technical University of Munich, Munich, Germany.
  • Cardona V Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona.
  • Caubet JC Department of the Child and Adolescent, Pediatric Allergy Unit, Geneva University Hospital, Geneva, Switzerland.
  • Cavkaytar Ö Department of Pediatric Allergy and Immunology, Faculty of Medicine, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey.
  • Elliott T New York University Medical Center, New York, New York, USA.
  • Esteban-Gorgojo I Department of Allergy, Hospital General de Villalba, Madrid, Spain.
  • Fonseca JA CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Gardner J Great North Children's Hospital, Newcastle, UK.
  • Gevaert P Department of Otorhinolaryngology, Ghent University, Ghent, Belgium.
  • Ghiordanescu I Elias Emergency University Hospital, Bucharest, Romania.
  • Hellings P Euforea, Brussels, Belgium.
  • Hoffmann-Sommergruber K Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
  • Fusun Kalpaklioglu A Department of Immunology and Allergic Diseases, Kirikkale University School of Medicine, Kırıkkale, Turkey.
  • Marmouz F Pole sanitaire du Vexin, Pontoise, France.
  • Meijide Calderón Á Allergy Service of University Hospital Complex of Vigo, Pontevedra, Spain.
  • Mösges R Faculty of Medicine, Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.
  • Nakonechna A Department of Allergy, Broadgreen Hospital, Liverpool, UK.
  • Ollert M Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Oteros J Center of Allergy and Environment (ZAUM), School of Medicine and Helmholtz Center Munich, Technical University of Munich, Munich, Germany.
  • Pajno G Allergy Unit- Department of Pediatrics, University of Messina, Messina, Italy.
  • Panaitescu C Family Medicine Solo Practice, RespiRO - Romanian Primary Care Respiratory Group, Bucharest, Romania.
  • Perez-Formigo D Department of Ophthalmology, Hospital Universitario de Torrejon, Madrid, Spain.
  • Pfaar O Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Pitsios C Allergy Outpatient Clinic, Medical School, University of Cyprus, Nicosia, Cyprus.
  • Rudenko M London Allergy and Immunology Centre, London, UK.
  • Ryan D Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
  • Sánchez-García S Allergy Unit, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Shih J Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Tripodi S Allergy Unit, Policlinico Casilino Rome, Italy.
  • Van der Poel LA Children's Allergy Service, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • van Os-Medendorp H Department of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands.
  • Varricchi G Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
  • Wittmann J Selbstregulierung Informationswirtschaft eV, Berlin, Germany.
  • Worm M Department of Dermatology and Allergology, Allergy-Center-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Agache I Transylvania University Brasov, Brasov, Romania.
Show more…
  • 2019-06-24
Published in:
  • Allergy. - 2020
English Mobile health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data and information flow, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the "Be He@lthy, Be Mobile" WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the "General Data Protection Regulation" and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of healthcare professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician- to patient-centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts and recommendations for future mHealth initiatives within EAACI are listed.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/171458
Statistics

Document views: 22 File downloads:
  • fulltext.pdf: 0